Patent · US Active

Glp-1 analogue formulations

US8546326B2 · kind B2 · utility

20Cited by

18References

15Claims

0Family size

Assignee

CAMURUS AB · SE

Inventors

Fredrik Joabsson · Lund, SE
Markus Johnsson · Lund, SE
Fredrik Tiberg · Lund, SE

Key dates

Filing date	Jun 6, 2006
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Aug 4, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions forming a low viscosity mixture of: a) at least one neutral diacyl lipid, such as a diacyl glycerol; b) at least one phospholipid, such as a phosphatidyl choline; c) at least one biotolerable solvent, such as an oxygen containing solvent; d) at least one GLP-1 analogue; wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The invention further relates to methods of treatment comprising administration of such compositions, especially in treating diabetes, and to pre-filled administration devices and kits containing the formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.